Innovative Medicines Initiative
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI is a joint undertaking between the European Union and the pharmaceutical industry association, the European Federation of Pharmaceutical Industries and Associations, EFPIA IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
In this section
If you require any help or guidance regarding IMI please contact the relevant UK National Contact Points for the health theme:
UK National Contact Point (Academia)
Ms Victoria Brewer
Telephone: 020 7395 2205
Victoria.Brewer@headoffice.mrc.ac.uk
UK National Contact Point (SMEs and Industry)
Octavio Pernas
Telephone: 01302 322633
octavio.pernas@betatechnology.co.uk
Useful websites
IMI website - Contains full information and rules for submission
EFPIA website